Global Nuclear Medicine Equipment Market was value US$ 6.8Bn in 2019 and is expected to reach US$ 16.1n by 2027 at a CAGR of 11.3 %.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.
The Nuclear medicine equipment is designed to solve the diagnostic challenges, a medical image using a small amount of radioactive material to diagnose and control the severity of or for treating numerous disease for instance cancer, heart diseases, neurological disorders, and other abnormalities within the body.
The increasing prevalence of disease among the geriatric population, durable product pipeline, and a growing demand for nuclear medicine procedures in the emerging market are expected to fuel market growth in the forecast years. The high cost of nuclear medicine equipment’s and reduced half-life radiopharmaceuticals hamper the growth of the nuclear medicine equipment market globally. Furthermore, lack of effective data & evidence that supports nuclear medicines improves the patient’s outcome, less reimbursement of medical imaging, and lack of trained physician and radiologist can restraint growth of global nuclear medicine equipment market.
Positron Emission Tomography (PET) dominated the industry in 2017 caused by high-resolution images provided by PET technology that is majorly used in oncology cases to obtain enhanced information about a tumour. Positron Emission Tomography (PET) is sub-segmented into standalone and hybrid. Cost-effectiveness of SPECT will significantly drive segment growth during the forecast period.
Cardiology application segment is expected to witness considerable growth over the coming years owing to increasing awareness about cardiac disorders, increasing the number of people suffering from cardiovascular diseases and rising adoption of a sedentary lifestyle and unhealthy diet escalating disease burden.
Region-wise, the Asia Pacific is anticipated to register the highest CAGR of 10.5% over the forecast period. Demand for nuclear medicine is growing in emerging markets such as China and India due to increasing disposable income, improving healthcare standards, and favourable reforms in foreign policies. China is dominating the Asia Pacific market and is likely to hold on to its leadership position through 2026.
The scope of Global Nuclear Medicine Equipment Market
Global Nuclear Medicine Equipment Market, by Product
• Single-Photon Emission Computed Tomography (SPECT)
o Standalone
o Hybrid
• Positron Emission Tomography (PET)
o Standalone
o Hybrid
Global Nuclear Medicine Equipment Market, by Application
• Neurology
• Oncology
• Cardiology
• Others
Global Nuclear Medicine Equipment Market, by End user
• Hospitals
• Imaging Centres
• Academic & Research Institutes
Global Nuclear Medicine Equipment Market, by Region
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• South America
Key players operating in Global Nuclear Medicine Equipment Market
• Philips Healthcare
• GE Healthcare
• Cardinal Health Inc.
• Siemens AG
• Digirad Corporation
• Mediso Medical Imaging Systems, Ltd.
• Toshiba Medical Systems Corporation
• DDD-Diagnostics A/S
• Neusoft Medical Systems Co. Ltd.
• Mallinckrodt plc
• SurgicEye GmbH
• CMR Naviscan Corporation
Global Nuclear Medicine Equipment Market Request For View Sample Report Page : @ https://www.maximizemarketresearch.com/request-sample/25509
About Us:
Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact info:
Name: Vikas Godage
Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.
Email: sales@maximizemarketresearch.com
Website:www.maximizemarketresearch.com